INKON Life Technology Co Ltd (SHE:300143) — Market Cap & Net Worth
Market Cap & Net Worth: INKON Life Technology Co Ltd (300143)
INKON Life Technology Co Ltd (SHE:300143) has a market capitalization of $814.84 Million (CN¥5.57 Billion) as of August 5, 2026. Listed on the SHE stock exchange, this China-based company holds position #9710 globally and #2462 in its home market, demonstrating a 7.37% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying INKON Life Technology Co Ltd's stock price CN¥7.43 by its total outstanding shares 749451604 (749.45 Million). See 300143 capital expenditure intensity to understand how much of operating cash flow is reinvested back into capital assets.
INKON Life Technology Co Ltd Market Cap History: 2015 to 2026
INKON Life Technology Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $1.71 Billion to $814.84 Million (-3.61% CAGR).
INKON Life Technology Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how INKON Life Technology Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.57x
INKON Life Technology Co Ltd's market cap is 0.57 times its annual revenue
Latest Price to Earnings (P/E) Ratio
15.81x
INKON Life Technology Co Ltd's market cap is 15.81 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.47 Billion | $432.45 Million | $55.08 Million | 3.41x | 26.74x |
| 2017 | $1.48 Billion | $329.23 Million | $122.40 Million | 4.49x | 12.07x |
| 2018 | $996.89 Million | $504.02 Million | $50.17 Million | 1.98x | 19.87x |
| 2019 | $1.03 Billion | $572.94 Million | -$703.41 Million | 1.80x | N/A |
| 2020 | $2.17 Billion | $661.05 Million | $128.11 Million | 3.28x | 16.95x |
| 2021 | $1.55 Billion | $1.09 Billion | -$364.08 Million | 1.42x | N/A |
| 2022 | $1.12 Billion | $1.16 Billion | -$595.92 Million | 0.96x | N/A |
| 2023 | $1.17 Billion | $1.47 Billion | $100.44 Million | 0.79x | 11.61x |
| 2024 | $1.01 Billion | $1.56 Billion | $115.42 Million | 0.65x | 8.74x |
| 2025 | $1.08 Billion | $1.89 Billion | $68.54 Million | 0.57x | 15.81x |
Competitor Companies of 300143 by Market Capitalization
Companies near INKON Life Technology Co Ltd in the global market cap rankings as of August 5, 2026.
Key companies related to INKON Life Technology Co Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #113 globally with a market cap of $186.27 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #180 globally with a market cap of $130.57 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #239 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #113 | Abbott Laboratories | NYSE:ABT | $186.27 Billion | $107.12 |
| #180 | Stryker Corporation | NYSE:SYK | $130.57 Billion | $341.20 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #239 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $86.68 |
INKON Life Technology Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, INKON Life Technology Co Ltd's market cap moved from $1.71 Billion to $ 814.84 Million, with a yearly change of -3.61%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥814.84 Million | -24.80% |
| 2025 | CN¥1.08 Billion | +7.39% |
| 2024 | CN¥1.01 Billion | -13.45% |
| 2023 | CN¥1.17 Billion | +4.52% |
| 2022 | CN¥1.12 Billion | -27.97% |
| 2021 | CN¥1.55 Billion | -28.69% |
| 2020 | CN¥2.17 Billion | +110.64% |
| 2019 | CN¥1.03 Billion | +3.41% |
| 2018 | CN¥996.89 Million | -32.54% |
| 2017 | CN¥1.48 Billion | +0.31% |
| 2016 | CN¥1.47 Billion | -13.67% |
| 2015 | CN¥1.71 Billion | -- |
End of Day Market Cap According to Different Sources
On Aug 4th, 2026 the market cap of INKON Life Technology Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $814.84 Million USD |
| MoneyControl | $814.84 Million USD |
| MarketWatch | $814.84 Million USD |
| marketcap.company | $814.84 Million USD |
| Reuters | $814.84 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About INKON Life Technology Co Ltd
INKON Life Technology Co., Ltd. focuses on building an ecosystem platform for providing medical services for tumors in China and internationally. It provides medical devices solutions for radiotherapy, life support, image enhancement, and chronic disease treatment; and oncology medical services, as well as equipment for cancer prevention, diagnosis, treatment, and rehabilitation. The company was … Read more